Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (261-270 of 663) with videos related to

Pageof 67
Sort By:
Antiviral Therapy|June 25, 2008
Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 originRichard W Price, Robin Parham, Jing Lu Kroll, et al.
AIDS (London, England)|July 1, 2014
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in AfricaMaya L Petersen, Linh Tran, Elvin H Geng, et al.
AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.
AIDS (London, England)|January 26, 2016
Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapyGabriela Khoury, Jenny L Anderson, Rémi Fromentin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Cardiopulmonary exercise testing to evaluate post-acute sequelae of COVID-19 ("Long COVID"): a systematic review and meta-analysisMatthew S Durstenfeld, Kaiwen Sun, Peggy M Tahir, et al.
The Journal of Infectious Diseases|January 15, 2004
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1Steven G Deeks, Jeffrey N Martin, Elizabeth Sinclair, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against <i>M. tuberculosis</i> antigenPaul Ogongo, Anthony Tran, Florence Marzan, et al.
Journal of Virological Methods|May 4, 2011
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliterSteven A Yukl, Peilin Li, Katsuya Fujimoto, et al.
AIDS (London, England)|September 2, 2011
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapyPeter W Hunt, Huyen L Cao, Conrad Muzoora, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2011
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementationElvin H Geng, James S Kahn, Olivia C Chang, et al.
Pageof 67

Showing results (261-270 of 663) with videos related to

Sort By:
Pageof 67
Antiviral Therapy|June 25, 2008
Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 originRichard W Price, Robin Parham, Jing Lu Kroll, et al.
AIDS (London, England)|July 1, 2014
Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in AfricaMaya L Petersen, Linh Tran, Elvin H Geng, et al.
AIDS (London, England)|July 9, 2014
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV diseaseÁlvaro H Borges, Jeffrey I Weitz, Gary Collins, et al.
AIDS (London, England)|January 26, 2016
Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapyGabriela Khoury, Jenny L Anderson, Rémi Fromentin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Cardiopulmonary exercise testing to evaluate post-acute sequelae of COVID-19 ("Long COVID"): a systematic review and meta-analysisMatthew S Durstenfeld, Kaiwen Sun, Peggy M Tahir, et al.
The Journal of Infectious Diseases|January 15, 2004
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1Steven G Deeks, Jeffrey N Martin, Elizabeth Sinclair, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL17 against <i>M. tuberculosis</i> antigenPaul Ogongo, Anthony Tran, Florence Marzan, et al.
Journal of Virological Methods|May 4, 2011
Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliterSteven A Yukl, Peilin Li, Katsuya Fujimoto, et al.
AIDS (London, England)|September 2, 2011
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapyPeter W Hunt, Huyen L Cao, Conrad Muzoora, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2011
The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementationElvin H Geng, James S Kahn, Olivia C Chang, et al.
Pageof 67